Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oragenics Inc (NYSE MKT LLC:OGEN)

0.8146
Delayed Data
As of Aug 23
 -0.0554 / -6.37%
Today’s Change
0.50
Today|||52-Week Range
2.93
-45.69%
Year-to-Date
No recent news for Oragenics Inc.

Today’s Trading

Previous close0.87
Today’s open0.90
Day’s range0.80 - 0.92
Volume67,111
Average volume (3 months)54,019
Market cap$42.7M
Dividend yield--
Data as of 08/23/2016

Growth & Valuation

Earnings growth (last year)-100.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+25.10%
P/E ratioNM
Price/Sales46.76
Price/Book7.33

Competitors

 Today’s
change
Today’s
% change
FCSCFibrocell Science In...-0.02-1.55%
CNATConatus Pharmaceutic...0.000.00%
GLMDGalmed Pharmaceutica...+0.06+1.59%
HEBHemispherx Biopharma...+0.01+6.55%
Data as of 08/23/2016

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$1.2M
Annual profit (last year)-$11.7M
Net profit margin-996.00%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Alan F. Joslyn
Chief Financial Officer, Secretary &
Treasurer
Michael O'Keefe Sullivan
Corporate headquarters
Tampa, Florida

Forecasts

Partner Offers

Search for Jobs